Erschienen in:
01.05.2008 | Populations at Risk
Racial Differences in Blood Pressure Control: Potential Explanatory Factors
verfasst von:
Hayden B. Bosworth, PhD, Benjamin Powers, MD, Janet M. Grubber, MSPH, Carolyn T. Thorpe, PhD, Maren K. Olsen, PhD, Melinda Orr, MEd, Eugene Z. Oddone, MHS
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 5/2008
Einloggen, um Zugang zu erhalten
Summary
Objective
The objective of the study was to identify potential explanatory factors for racial differences in blood pressure (BP) control.
Design
The design of the study was a cross-sectional study
Patients/Participants
The study included 608 patients with hypertension who were either African American (50%) or white (50%) and who received primary care in Durham, NC.
Measurements and Main Results
Baseline data were obtained from the Take Control of Your Blood pressure study and included clinical, demographic, and psychosocial variables potentially related to clinic BP measures. African Americans were more likely than whites to have inadequate baseline clinic BP control as defined as greater than or equal to 140/90 mmHg (49% versus 34%; unadjusted odds ratio [OR] 1.8; 95% confidence interval [CI] 1.3–2.5). Among factors that may explain this disparity, being older, reporting hypertension medication nonadherence, reporting a hypertension diagnosis for more than 5 years, reporting high levels of stress, being worried about hypertension, and reporting an increased number of medication side effects were related to inadequate BP control. In adjusted analyses, African Americans continue to have poor BP control relative to whites; the magnitude of the association was reduced (OR = 1.5; 95% CI 1.0–2.1). Medication nonadherence, worries about hypertension, and older age (>70) continued to be related to poor BP control.
Conclusions
In this sample of hypertensive patients, there were a number of factors associated with poor BP control that partially explained the observed racial disparity in hypertension control including age, medication nonadherence, and worry about BP. Medication nonadherence is of particular interest because it is a potentially modifiable factor that might be used to reduce the racial disparity in BP control.